Recently, Gαh overexpression has been observed in breast [11, 12], colon [13], and ovarian cancers [14]; non-small cell lung cancer [15]; and renal cell carcinoma [16] and has been shown to be associated with advanced disease stages and metastatic spread. This evidence concerns the gene GDA and ovarian carcinoma.